Serum periostin as a marker of TH2-dependent eosinophilic airway inflammation - 29/08/12
Doi : 10.1016/j.jaci.2012.07.021
Parameswaran Nair, MD, PhD, FRCP, FRCPC a, ⁎ 
, Monica Kraft, MD b
, Monica Kraft, MD b a Division of Respirology, McMaster University, Hamilton, Ontario, Canada
b Division of Pulmonary & Critical Care Medicine, Duke University, Durham, NC
Corresponding author: Parameswaran Nair, MD, PhD, FRCP, FRCPC, McMaster University, Firestone Institute for Respiratory Health, 50 Charlton Ave E, St Joseph’s Healthcare, Hamilton, Ontario L8N 4A6, Canada.Key words : Asthma, eosinophils, biomarker, periostin
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: P. Nair has consultant arrangements with Roche and has received grants from GlaxoSmithKline. M. Kraft has received grants from GlaxoSmithKline, Merck, Asthmatx (Boston Scientific), Eumedics, Novartis, Genentech, and the National Institutes of Health and has received a stipend from the American Thoracic Society. |
© 2012
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 130 - N° 3
P. 655-656 - septembre 2012 Retour au numéro
Article précédent
- Household mold as a predictor of asthma risk: Recent progress, limitations, and future directions
- Nathan Rabinovitch
- Sensitization and allergic histories differ between black and white pregnant women
- Ganesa Wegienka, Christine L.M. Joseph, Suzanne Havstad, Edward Zoratti, Dennis Ownby, Christine Cole Johnson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?